Concourse Financial Group Securities, Inc. Passage Bio, Inc. Call Options Transaction History
Concourse Financial Group Securities, Inc.
- $1.52 Billion
- Q1 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding PASG
# of Institutions
52Shares Held
33MCall Options Held
20.3KPut Options Held
500-
Orbimed Advisors LLC San Diego, CA10.1MShares$9.01 Million0.31% of portfolio
-
Versant Venture Management, LLC San Francisco, CA4.96MShares$4.41 Million9.33% of portfolio
-
Vestal Point Capital, LP New York, NY4.5MShares$4.01 Million0.5% of portfolio
-
New Leaf Venture Partners, L.L.C. New York, NY2.5MShares$2.22 Million2.96% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.07MShares$1.84 Million0.0% of portfolio
About Passage BIO, Inc.
- Ticker PASG
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,463,200
- Market Cap $48.5M
- Description
- Passage Bio, Inc., a genetic medicines company, develops transformative therapies for central nervous system diseases. It develops PBGM01, which utilizes a proprietary, AAVhu68 capsid to deliver to the brain and peripheral tissues a functional GLB1 gene encoding lysosomal acid beta-galactosidase for infantile GM1; PBFT02, which utilizes an AAV1 ...